Let's talk medical research

Many elements factor into the success of a clinical trial patient recruitment campaign. If issues arise within the recruitment pipeline, large-scale factors such as a lack of patients are often the first variables to be considered; however, smaller, less noticeable issues may be to blame. In this blog, we're sharing a few key things that may seem small but can have a large impact on patient ...

Patient-reported outcomes (PROs) are "any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else," according to the FDA. They are also a way to include the patient voice in clinical trials.

At Antidote, we share a variety of patient stories, spanning many conditions and individual backgrounds, but one common thread runs throughout — the defining power of the story to help patients and caregivers cope emotionally with an illness. Click here to read, watch, or listen to the stories of the following:

In the end, it was vanity that brought Shanelle Gabriel to the doctor who diagnosed her lupus. At least that’s how she tells it.

I was sitting in the balcony seats in the Opera House at the John F. Kennedy Center for the Performing Arts when I first heard Ed Gavagan tell his story. If you’ve watched the Kennedy Center Honors on TV, these seats are reserved for cultural icons — musical legends, film and stage royalty. Extraordinary people. It was quite a humbling spot for an ordinary person, but since I was working the show ...

It all started with a phone call. Sandy, in tears, called Ira, her husband of over 30 years. She told him that she couldn’t find the Pilates studio where she practiced for years. It was a trip she had taken from their apartment in New York City countless times. The following week, they made an appointment with a neurologist. Soon after, Sandy would be given a diagnosis of mild cognitive ...

With a long line of disappointments in failed clinical trials, the last few years have not been good ones for drug development in Alzheimer’s disease. TURNING POINT is a documentary, produced in conjunction with BrightFocus Foundation, that follows the journey of researchers and patients working together on a trial for a new Alzheimer’s drug. The drug solanezumab, investigated by Eli Lilly & ...

Clinical trial site selection is an important step that can help prevent delays and other challenges once your trial is up and running. It also tends to be a rather burdensome step: Today, it takes an average of 31.4 weeks from site identification to the completion of the study start-up phase, which is one month longer than the average duration observed 10 years ago, according to a report from ...

Though clinical research is a requirement for any new drug or treatment to be developed, many people are unaware of what participating in one of these studies entails. Emily Schaller, founder and CEO of the Rock CF Foundation, talked with Antidote about her experience participating in several clinical trials for cystic fibrosis, a progressive lung condition that she has lived with since she was ...

Cancer Treatment Centers of America (CTCA) is a four-hospital system with a national footprint. As a specialty provider in cancer care, the system sees 20,000 cancer patients annually and consistently ranks in the top 3% of all hospitals regarding patient satisfaction. In addition, the organization has worked to harness the therapeutic benefits of patient storytelling through a partnership with ...